PANEL DISCUSSION: Evaluate the Current Challenges, Approaches and Opportunities in Treating Glioblastoma
Time: 1:50 pm
day: Day One
Details:
- A year on from the inaugural GBM Drug Development meeting: What have we learnt?
- How can drug developers cut to the real barriers, and debate what is truly required to break through to successful treatments for GBM?
- The impact of COVID-19 and its repercussions on existing clinical trials
Speakers:
Jann N. Sarkaria, M.D., is a consultant in the Department of Radiation Oncology at Mayo Clinic in Rochester, Minnesota and holds the academic rank of professor of radiation oncology, Mayo Clinic College of Medicine and Science. Dr. Sarkaria earned his B.S. in biology and chemistry from the University of California at Irvine and his M.D.…Read more
Dr. Patrick Wen is a Professor of Neurology at Harvard Medical School, President of the Society For Neuro-Oncology, Co-PI of thr Adult Brain Tumor Consortium and former Editor-In-Chief of Neuro-Oncology. He received his medical degree from Barts and The London School of Medicine and Dentistry and completed his neurology residency in the Harvard-Longwood Neurology Training…Read more
